Stellar Biotechnologies Company Profile (NASDAQ:SBOT)

About Stellar Biotechnologies

Stellar Biotechnologies logoStellar Biotechnologies, Inc. is a biotechnology company. The Company is engaged in the aquaculture, research and development, manufacture and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a range of diseases. The Company's core business is developing and commercializing Keyhole Limpet Hemocyanin for use in immunotherapy and immunodiagnostic applications. The Company's Stellar KLH product offerings include Stellar KLH protein for conjugation and as carrier molecule in immunotherapy development; Stellar KLH protein and enzyme-linked immunosorbent assay (ELISA) test kits for immune function testing, and Custom KLH formulations, adjuvants, conjugations and fill finishes for preclinical research and drug development applications.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SBOT
  • CUSIP:
Key Metrics:
  • Previous Close: $1.61
  • 50 Day Moving Average: $1.86
  • 200 Day Moving Average: $2.18
  • 52-Week Range: $1.47 - $6.93
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.28
  • P/E Growth: 0.00
  • Market Cap: $15.51M
  • Outstanding Shares: 10,136,000
  • Beta: 0.55
Profitability:
  • Net Margins: -528.08%
  • Return on Equity: -49.34%
  • Return on Assets: -46.23%
Debt:
  • Current Ratio: 17.63%
  • Quick Ratio: 17.10%
Additional Links:
Companies Related to Stellar Biotechnologies:

Analyst Ratings

Consensus Ratings for Stellar Biotechnologies (NASDAQ:SBOT) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $4.00 (161.44% upside)

Analysts' Ratings History for Stellar Biotechnologies (NASDAQ:SBOT)
Show:
DateFirmActionRatingPrice TargetDetails
12/2/2016Maxim GroupLower Price TargetBuy$7.00 -> $4.00View Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for Stellar Biotechnologies (NASDAQ:SBOT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2017        
2/6/2017Q1 2017($0.10)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Stellar Biotechnologies (NASDAQ:SBOT)
Current Year EPS Consensus Estimate: $-0.42 EPS
Next Year EPS Consensus Estimate: $-0.29 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.17)($0.17)($0.17)
Q2 20161($0.18)($0.18)($0.18)
Q3 20161($0.19)($0.19)($0.19)
Q1 20171($0.18)($0.18)($0.18)
Q2 20171($0.15)($0.15)($0.15)
Q3 20171($0.14)($0.14)($0.14)
Q4 20171($0.13)($0.13)($0.13)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Stellar Biotechnologies (NASDAQ:SBOT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Stellar Biotechnologies (NASDAQ:SBOT)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Stellar Biotechnologies (NASDAQ:SBOT)
DateHeadline
News IconStellar Biotechnologies Inc SBOT Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:SBOT)
www.bioportfolio.com - February 25 at 7:15 PM
News IconEye on Technical Levels for Stellar Biotechnologies Inc (SBOT) - The Standard (NASDAQ:SBOT)
6milestandard.com - February 24 at 9:37 PM
News IconShares in Focus: Stellar Biotechnologies, Inc. (NASDAQ:SBOT) - Benton Bulletin (NASDAQ:SBOT)
bentonbulletin.com - February 22 at 7:55 PM
kcregister.com logoActive Watch List: Grupo Aeroportuario (NASDAQ:OMAB), Pingtan Marine Enterprise Ltd. (NASDAQ:PME), Stellar ... - KC Register (NASDAQ:SBOT)
www.kcregister.com - February 10 at 2:12 AM
finance.yahoo.com logoSBOT: Q1 Light On Revenue But Clinical Trial Progression Suggests Growth Ahead (NASDAQ:SBOT)
finance.yahoo.com - February 10 at 2:12 AM
prnewswire.com logoStellar Biotechnologies Reports First Quarter 2017 Financial Results - PR Newswire (press release) (NASDAQ:SBOT)
www.prnewswire.com - February 7 at 8:08 AM
us.rd.yahoo.com logo8:24 am Stellar Biotechnologies issues a statement congratulating Neovacs S.A. for its decision to extend the development of its lupus drug for Type 1 diabetes (NASDAQ:SBOT)
us.rd.yahoo.com - February 7 at 12:53 AM
finance.yahoo.com logoStellar Biotechnologies Reports First Quarter 2017 Financial Results (NASDAQ:SBOT)
finance.yahoo.com - February 6 at 7:49 PM
finance.yahoo.com logoStellar Biotechnologies Congratulates Partner's Decision to Extend Drug Development for Diabetes (NASDAQ:SBOT)
finance.yahoo.com - February 6 at 8:34 AM
News IconTechnical Watch on These Shares: Stellar Biotechnologies Inc. (SBOT) - Sherwood Daily (NASDAQ:SBOT)
sherwooddaily.com - January 31 at 10:31 PM
News IconAre There Any Catalysts to Propel This Stock Forward: Stellar Biotechnologies, Inc. (:SBOT) - Prospect Journal (NASDAQ:SBOT)
prospectjournal.com - January 20 at 6:39 AM
News IconEquity Insight: Indicator Review for Stellar Biotechnologies Inc. (SBOT) - Sherwood Daily (NASDAQ:SBOT)
sherwooddaily.com - January 17 at 8:06 PM
News IconPrimed for Breakout or Bust? A look at Stellar Biotechnologies, Inc. (:SBOT) - Prospect Journal (NASDAQ:SBOT)
prospectjournal.com - January 17 at 8:06 PM
News IconSmall Cap Concentration on Stellar Biotechnologies, Inc. (:SBOT) - Prospect Journal (NASDAQ:SBOT)
prospectjournal.com - January 17 at 8:06 PM
finance.yahoo.com logo7:31 am Stellar Biotechnologies to expand production of its Stellar KLH products under a recently established Mexican subsidiary (NASDAQ:SBOT)
finance.yahoo.com - January 11 at 10:27 PM
News IconIgniting Curiosity on This Name, Investor Update on Stellar Biotechnologies, Inc. (:SBOT) - Prospect Journal (NASDAQ:SBOT)
prospectjournal.com - January 5 at 6:29 AM
finance.yahoo.com logoStellar Biotechnologies to Present at Biotech Showcase Conference (NASDAQ:SBOT)
finance.yahoo.com - January 5 at 6:29 AM
News IconInside the Numbers on Shares of Stellar Biotechnologies, Inc. (NASDAQ:SBOT) - Wall Street Beacon (NASDAQ:SBOT)
wsbeacon.com - December 30 at 12:43 AM
News IconAre There Any Catalysts to Propel Shares of Stellar Biotechnologies, Inc. (:SBOT) - Prospect Journal (NASDAQ:SBOT)
prospectjournal.com - December 29 at 8:34 AM
News IconIs This Stock Ready to Rumble: Stellar Biotechnologies, Inc. (:SBOT) - Prospect Journal (NASDAQ:SBOT)
prospectjournal.com - December 24 at 8:08 AM
News IconInvestor Wire: Keeping an Eye on Stellar Biotechnologies, Inc. (NASDAQ:SBOT) - Wall Street Beacon (NASDAQ:SBOT)
wsbeacon.com - December 20 at 8:34 PM
News IconMarket Focus: Zooming in on Shares of Stellar Biotechnologies, Inc. (NASDAQ:SBOT) - Business Daily Leader (NASDAQ:SBOT)
businessdailyleader.com - December 20 at 2:33 PM
News IconCan This Stock Grab Upward Traction: Stellar Biotechnologies, Inc. (:SBOT) - Prospect Journal (NASDAQ:SBOT)
prospectjournal.com - December 20 at 2:33 PM
capitalcube.com logoStellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: 2016 By the Numbers : December 19, 2016 (NASDAQ:SBOT)
www.capitalcube.com - December 20 at 2:33 PM
finance.yahoo.com logoSBOT: 2016 A Solid Year, Both Financially and Operationally (NASDAQ:SBOT)
finance.yahoo.com - December 20 at 2:33 PM
finance.yahoo.com logoSTELLAR BIOTECHNOLOGIES, INC. Financials (NASDAQ:SBOT)
finance.yahoo.com - December 20 at 2:33 PM
finance.yahoo.com logoStellar Biotechnologies Reports Fiscal Year 2016 Financial Results (NASDAQ:SBOT)
finance.yahoo.com - December 14 at 10:01 PM
biz.yahoo.com logoSTELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements (NASDAQ:SBOT)
biz.yahoo.com - December 14 at 10:01 PM
News IconStellar Biotechnologies Announces Fiscal Year 2016 Corporate Update Conference Call - Yahoo Sports (NASDAQ:SBOT)
sports.yahoo.com - December 13 at 8:17 AM
News IconGrowth Story Unfolding for Stellar Biotechnologies, Inc. (:SBOT) - Prospect Journal (NASDAQ:SBOT)
prospectjournal.com - December 13 at 8:17 AM
News IconMF Rank Review for Stellar Biotechnologies, Inc. (NASDAQ:SBOT) - Wall Street Beacon (NASDAQ:SBOT)
wsbeacon.com - December 13 at 12:47 AM
finance.yahoo.com logoStellar Biotechnologies Announces Fiscal Year 2016 Corporate Update Conference Call (NASDAQ:SBOT)
finance.yahoo.com - December 12 at 9:17 AM
News IconStock Survey: Checking Levels for Stellar Biotechnologies, Inc. (NASDAQ:SBOT) - Wall Street Beacon (NASDAQ:SBOT)
wsbeacon.com - December 10 at 12:36 AM
marketwired.com logoStellar Biotechnologies Appoints Pharma and Capital Markets Experts to Board of Directors - Marketwired (press release) (NASDAQ:SBOT)
www.marketwired.com - December 9 at 7:36 PM
biz.yahoo.com logoSTELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial (NASDAQ:SBOT)
biz.yahoo.com - December 9 at 7:36 PM
fxpips.com logoStocks Gapping Up Before the Bell – JTPY, DFFN, III, MAG, PN, GENC, FIVE, SBOT, ZUMZ (NASDAQ:SBOT)
www.fxpips.com - December 5 at 9:17 AM
marketexclusive.com logoBMO Capital Markets has upgraded the stock of Workday Inc. (NYSE:WDAY) - Market Exclusive (NASDAQ:SBOT)
marketexclusive.com - December 2 at 11:43 AM
News IconToday's Rating: Maxim Group Keeps a Buy Rating on Stellar Biotechnologies (NASDAQ:SBOT) and $4 Target - Thorold News (NASDAQ:SBOT)
www.whatsonthorold.com - December 2 at 11:43 AM
News IconInvestor Focus on Shares of Stellar Biotechnologies, Inc. (NASDAQ:SBOT) - Business Daily Leader (NASDAQ:SBOT)
businessdailyleader.com - December 2 at 11:43 AM
News IconCompany Focus on Stellar Biotechnologies, Inc. (NASDAQ:SBOT) - Wall Street Beacon (NASDAQ:SBOT)
wsbeacon.com - November 29 at 3:14 PM
News IconStock Concentration on Shares of Stellar Biotechnologies, Inc. (NASDAQ:SBOT) - Business Daily Leader (NASDAQ:SBOT)
businessdailyleader.com - November 28 at 3:41 PM
News IconHeadlining Penny Stock: In Focus Stellar Biotechnologies, Inc. (:SBOT) - Duncan Research (NASDAQ:SBOT)
www.duncanindependent.com - November 26 at 2:29 PM
News IconLooking at the Technicals for Stellar Biotechnologies Inc. (SBOT) - MicroCap Wired (NASDAQ:SBOT)
www.microcapwired.com - November 21 at 7:50 PM
News IconPenny Stock Focus: Narrowing the Lens On Stellar Biotechnologies, Inc. (:SBOT) - Duncan Research (NASDAQ:SBOT)
www.duncanindependent.com - November 18 at 6:56 PM
News IconPenny Stock Making Waves: Taking a Second Look at Stellar Biotechnologies, Inc. (:SBOT) - Duncan Research (NASDAQ:SBOT)
www.duncanindependent.com - November 17 at 11:32 AM
News IconMarket Focus: Checking Indicators on Shares of Stellar Biotechnologies Inc. (SBOT) - MicroCap Wired (NASDAQ:SBOT)
www.microcapwired.com - November 16 at 11:01 AM
4-traders.com logoDGAP-News: NEOVACS ACQUIRES INTERFERON ALPHA MANUFACTURING TECHNOLOGY FROM AMEGABIOTECH (NASDAQ:SBOT)
www.4-traders.com - November 15 at 10:59 AM
News IconCCI Level Check for Stellar Biotechnologies Inc. (SBOT) - MicroCap Wired (NASDAQ:SBOT)
www.microcapwired.com - November 12 at 9:50 AM
News IconPenny Stock News: Looking Closer At Stellar Biotechnologies, Inc. (:SBOT) - Duncan Research (NASDAQ:SBOT)
www.duncanindependent.com - November 12 at 9:50 AM
News IconSignal Watch: Checking the Numbers for Stellar Biotechnologies Inc. (SBOT) - MicroCap Wired (NASDAQ:SBOT)
www.microcapwired.com - November 10 at 7:15 PM

Social

What is Stellar Biotechnologies' stock symbol?

Stellar Biotechnologies trades on the NASDAQ under the ticker symbol "SBOT."

Where is Stellar Biotechnologies' stock going? Where will Stellar Biotechnologies' stock price be in 2017?

1 brokers have issued 12-month price objectives for Stellar Biotechnologies' shares. Their predictions range from $4.00 to $4.00. On average, they expect Stellar Biotechnologies' stock price to reach $4.00 in the next twelve months.

When will Stellar Biotechnologies announce their earnings?

Stellar Biotechnologies is scheduled to release their next quarterly earnings announcement on Monday, May, 8th 2017.

How do I buy Stellar Biotechnologies stock?

Shares of Stellar Biotechnologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Stellar Biotechnologies stock cost?

One share of Stellar Biotechnologies stock can currently be purchased for approximately $1.53.

Stellar Biotechnologies (NASDAQ:SBOT) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Stellar Biotechnologies (NASDAQ:SBOT)

Earnings History Chart

Earnings by Quarter for Stellar Biotechnologies (NASDAQ:SBOT)

Dividend History Chart

Dividend Payments by Quarter for Stellar Biotechnologies (NASDAQ:SBOT)

Last Updated on 2/26/2017 by MarketBeat.com Staff